Biotech News
Artivion Reports First Quarter 2026 Financial Results and Announces Exercise of Option to Acquire Endospan
investors.artivion.com2026-05-07 20:17 EST
First Quarter & Recent Business Highlights: Achieved revenue of $116.3 million in the first quarter of 2026 versus $99.0 million in the first quarter of 2025, an increase of 18% on a GAAP basis and 12% on a non-GAAP constant currency basis Net income for the first quarter of 2026 was $1.4 million,
